NBA approves HIV prevention Vaccine Trial
Notice: Undefined index: catFilterList in /home/zambi/public_html/wp-content/plugins/wp-likes/api.php on line 243
By Derrick Sinjela THE National Biosafety Authority (NBA) has approved a second HIV vaccine clinical trial in Lusaka and Ndola at phase two for the prevention of HIV-1 infection in women involving 500 participants to be conducted by the Centre for Infectious Disease Research in Zambia (CIDRZ) and the Zambia Emory HIV Research Project (ZEHRP). Last year, NBA approved one research trial involving HIV vaccine presented by CIDRZ on the safety and immunogenicity of HVTN 120/ALVAC which is being conducted in Lusaka) and a Malaria research involving use of modified bacteria to control malaria (by Macha Research Trust, which is...